Coming Soon

LunaCTherapeutics specializes in developing advanced therapeutic solutions for various medical conditions, focusing on innovative approaches to enhance patient care and treatment outcomes.
Spinout Company
Public Funding Received
2020-06-01
Continuity Award of Development of First-in class small molecule preclinical candidate anticoagulant targeting activated factor XII with minimal risk of bleeding -105439
Feasibility Studies
2019-09-01
Development of First-In Class Small Molecule Preclinical Candidate Anticoagulant Targeting Activated Factor XII with Minimal Risk of Bleeding
Collaborative R&D